Professional Documents
Culture Documents
For Research Use Only. Not for use in diagnostic procedures. The world leader in serving science
Improved survival over existing therapies drive increased interest in immuno-oncology research
10
10
7
6
5 3
2
0
2015 2018 2020
Pessimistic Frost & Sullivan Optimistic
Frost & Sullivan, July 2016
Sharma P, Allison JP. Cell, 161: 205214, 2015
Potential to respond
IHC
Potential to respond
Lower potential to
respond
Tumor microenvironment
Adapted from Upreti et al., Transl Canc Res 2:4 (2013)
RecoverAll Oncomine
Total Nucleic Acid Immune Ion Chef Ion Torrent
Ion S5 System
Isolation Kit for Response System Suite Plug-in
FFPE Research Assy
Two-day workflow*
High sensitivity to low expressing genes, broad dynamic range, and with
excellent reproducibility Multiplexing
per chip
Activation )
proliferatio
n
cytotoxicity
CD ) )
8+ T
cell
More reads
across low
expressors
Genes associated with checkpoint pathways Genes associated TIL* Genes associated with
with drug targets nterferon signaling
Units on both axes are log2(RPM). Each plot shows the expression of the same gene
either on Immune Response or the transcriptome panel
Data show that Ion AmpliSeq Transcriptome scales linearly between two panel sizes but
the Oncomine Immune Response Research Assay offers more robust estimate for
Transcriptome expression
nCounter
Nanostring
Oncomine
OIRRA
0.15
Immune
Response
Research
Assay
Fraction of genes
0.10
0.05
0.00
-5 0 5 10 15 20
Gene expression in log2
Gene expression in log2
Each line represents the distribution of genes in 1 run
Distribution of gene expression shows the expression all of genes in each sample
Dynamic range is estimated by the highest and lowest genes detected in each sample
80
% genes detected
60
40
20
0
CR.4.1258.2
CR.4.1258.2.1
CR.4.1296.7
CR.9.1251.6
CR.9.1251.6.1
CR.9.1251.6.2
CR.9.1270.3
CR.9.1270.3.1
NP.13634.3.A.1
NP.16332.5
NP.16332.5.1
X131503T26.A.1
NP.16585.4.A.1
CR.4.1493.1.A
NP.13634.3.A
NP.13634.3.B
X131503T26.A
X131503T26.B
CR.19.1452.8.A
NP.16585.4.A
NP.16585.4.B
Sample
NSCLC
Breast Head & Neck Melanoma RCC
1-correlation
Correlation Correlation
0.00 0.10 0.20 0.30 0.00 0.10 0.20
100
Melanoma_X131503T26_R4 H&N_NP.13634.3.A
Melanoma
95
Melanoma_X131503T26.rep_R1 H&N_NP.13634.3.B
98
Melanoma_X131503T26_R1 NSCLC_CR.19.1452.8.A
100
Melanoma_NP.16332.5_R1 NSCLC_CR.19.1452.8.B
Melanoma_NP.16332.5_R4 RCC_NP.16585.4.A
NSCLC NSCLC_CR.19.1452.8_R4 RCC_NP.16585.4.B
69
au
RCC_NP.16585.4_R2 100 64 NSCLC_CR.19.1100.2.A
C
RC
Nanostring
RCC_NP.16585.4_R1 NSCLC_CR.19.1100.2.B
RCC_NP.16585.4_R4 H&N_CR.9.1280.6
OIRRA
H&N_CR.9.1251.6_R2 H&N_CR.9.1251.6
97
64
70
H&N_CR.9.1251.6_R1 H&N_CR.9.1270.3
H&N_CR.9.1251.6_R4 71 Melanoma_X131503T26.A
100
H&N
H&N_NP.13634.3_R4 Melanoma_X131503T26.B
94
H&N_NP.13634.3_R1 Melanoma_NP.16332.5
60
H&N_NP.13634.3.rep_R1 Breast_CR.4.1493.1.A
75
100
H&N_CR.9.1270.3_R1 Breast_CR.4.1493.1.B
H&N_CR.9.1270.3_R4 Breast_CR.4.1296.7
Breast_CR.4.1296.7_R4 Breast_CR.4.1292.3
83
Breast
Breast_CR.4.1493.1_R4
87
Breast_CR.4.1258.2
84
Breast_CR.4.1258.2_R1 Breast_CR.4.1484.1
Breast_CR.4.1258.2_R4
Oncology Research
Specimen
Oncomine
OneTouch 2 Ion 318 Chip
Immune
Hi-Q View 1-4 libraries
Response
Templating Kit
Research Assay
Kit (32 Libraries)
Analysis
solution with
10 ng Torrent
total 3 SuiteTM
RNA Software
Oncomine Immune
Ion Chef System Ion 520 Chip 1-4 libraries
Response Research
520/530 Templating Ion 530 Chip 2-8 libraries
Assay Kit Chef Ready
Kit
(32 Libraries)
Number of genes
0
10
20
30
40
50
60
Linearity of absolute fold change estimates Linearity of relative fold change estimates
Observed
Observed f1<f2<f3..<f395
Expected Expected
False False
Observed Expected True neg positive negative True pos TP/(TP+FN) TN/(TN+FP)
titration
abs fc absolute both titration sig not.sig
q_value titration fc pure not sig pure not.sig pure sig both sig Sensitivity Specificity
0.05 0 0 14 12 6 270 97.8% 53.8%
0.001 0 0 29 34 7 232 97.1% 46.0%
0.05 0 2 20 73 0 209 100.0% 21.5%
0.001 0 2 35 67 1 199 99.5% 34.3%
0.05 2 2 93 0 51 158 75.6% 100.0%
0.001 2 2 95 7 49 151 75.5% 93.1%
0.05 0 4 20 136 0 146 100.0% 12.8%
0.001 0 4 36 123 0 143 100.0% 22.6%
0.05 2 4 131 25 13 133 91.1% 84.0%
0.001 2 4 131 28 13 130 90.9% 82.4%
0.05 4 4 155 1 13 133 91.1% 99.4%
0.001 4 4 155 4 13 130 90.9% 97.5%
2 fold differential expression difference can be detected with >75% sensitivity and >99% specificity
4 fold differential expression difference can be detected with >90% sensitivity and >99% specificity
Ct
HL-60 Normal
lung